Literature DB >> 1328067

Presence and physical state of HPV DNA in prostate and urinary-tract tissues.

A Rotola1, P Monini, D Di Luca, A Savioli, R Simone, P Secchiero, A Reggiani, E Cassai.   

Abstract

Neoplastic and non-neoplastic tissues from the urinary tract and the prostate were analyzed for the presence of human papillomavirus (HPV) DNA. The analysis was performed by PCR using primers specific for HPV 6/11 and 16. HPV DNA was present in bladder, ureter, kidney and prostate, with percentages ranging between 46% and 87%. Benign and oncogenic HPV types were detected with similar frequencies both in non-neoplastic and in neoplastic biopsies, and HPV 16 was not preferentially associated with malignant lesions. In all instances, small amounts of HPV DNA were present in the tissues, suggesting the absence of productive infection. Analysis of the physical state of HPV DNA performed by 2-dimensional gel electrophoresis and Southern blot hybridization revealed that HPV 16 DNA harbored in the urinary tract can be integrated also in non-neoplastic tissues. The results indicate that HPV 16 does not seem to be associated with urinary-tract and prostate oncogenesis, but that these tissues may represent an important reservoir for the transmission of HPV types normally infecting the genital tract.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328067     DOI: 10.1002/ijc.2910520306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Occurrence of human papillomavirus types 16 and 18 in benign prostatic hyperplasia tissues of Saudi patients.

Authors:  M N al-Ahdal; A H Kardar; A M Selim; G Kessie
Journal:  Genitourin Med       Date:  1996-10

2.  Association between human papillomavirus and prostate cancer: A meta-analysis.

Authors:  Binbin Yin; Weiwei Liu; Pan Yu; Chunhua Liu; Yue Chen; Xiuzhi Duan; Zhaoping Liao; Yuhua Chen; Xuchu Wang; Xiaoyan Pan; Zhihua Tao
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

3.  Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.

Authors:  Y Soini; K Nuorva; D Kamel; R Pöllänen; K Vähäkangas; V P Lehto; P Pääkkö
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

4.  Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.

Authors:  Y Lin; Q Mao; X Zheng; K Yang; H Chen; C Zhou; L Xie
Journal:  Ir J Med Sci       Date:  2011-03-12       Impact factor: 1.568

Review 5.  Multiple pathogens and prostate cancer.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Infect Agent Cancer       Date:  2022-05-30       Impact factor: 3.698

6.  Impact of sexual habits on the clinical evaluation of male HPV infection.

Authors:  A Rotola; S Costa; P Monini; C Vendra; G Guida; P Terzano; D Di Luca; G Martinelli; E Cassai
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

7.  Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis.

Authors:  Lin Yang; Shuanghua Xie; Xiaoshuang Feng; Yuheng Chen; Tongzhang Zheng; Min Dai; Cindy Ke Zhou; Zhibin Hu; Ni Li; Dong Hang
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

8.  Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-02-11

Review 9.  Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers.

Authors:  Maryam Soheili; Hossein Keyvani; Marzieh Soheili; Sherko Nasseri
Journal:  Med J Islam Repub Iran       Date:  2021-05-22

10.  Human Papillomavirus in Urothelial Carcinoma of Bladder: An Indian study.

Authors:  Uttam K Mete; Sunil Shenvi; Mini P Singh; Anuradha Chakraborti; Nandita Kakkar; Radha Kanta Ratho; Arup K Mandal
Journal:  Int J Appl Basic Med Res       Date:  2018 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.